rs202040659
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_006514.4(SCN10A):c.4552G>A(p.Val1518Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000514 in 1,614,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1518A) has been classified as Uncertain significance.
Frequency
Consequence
NM_006514.4 missense
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN10A | NM_006514.4 | c.4552G>A | p.Val1518Ile | missense_variant | Exon 27 of 28 | ENST00000449082.3 | NP_006505.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | c.4552G>A | p.Val1518Ile | missense_variant | Exon 27 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.4549G>A | p.Val1517Ile | missense_variant | Exon 26 of 27 | ENSP00000495595.1 | ||||
| SCN10A | ENST00000655275.1 | c.4576G>A | p.Val1526Ile | missense_variant | Exon 27 of 28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152168Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000717 AC: 18AN: 251220 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461824Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 727212 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000177 AC: 27AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74460 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
BS2 -
Functional studies suggest this variant affects sodium channel function (PMID: 31195250); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31195250) -
Brugada syndrome Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at